Cargando…

330. Outpatient Parenteral Antimicrobial Therapy in People who Inject Drugs

BACKGROUND: People with opioid use disorder (OUD) make up a significant and increasing proportion patients requiring outpatient parenteral antimicrobial therapy (OPAT). Many of these patients do not receive OUD treatment during their index hospitalization, leading to missed opportunities for treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawes, Armani, Yanek, Lisa, Buresh, Megan E, Bodnar, Alia, Keller, Sara C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677293/ http://dx.doi.org/10.1093/ofid/ofad500.401

Ejemplares similares

Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature
por: Suzuki, Joji, et al.
Publicado: (2018)

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
por: Rizvi, Hira, et al.
Publicado: (2018)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

325. Outcomes of Outpatient Parenteral Antimicrobial Therapy in the Solid Organ Transplant Population
por: Dillon, William P, et al.
Publicado: (2023)

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
por: Huang, Victoria, et al.
Publicado: (2017)

1933. Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children
por: Krah, Nathan, et al.
Publicado: (2018)

1855. Antimicrobial Stewardship (AMS) and the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting
por: Friedman, N Deborah
Publicado: (2018)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
por: Van Anglen, Lucinda J, et al.
Publicado: (2017)

353. Outpatient parenteral antimicrobial therapy (OPAT) in managing vertebral osteomyelitis
por: Villacorta Cari, Evelyn, et al.
Publicado: (2023)

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2018)

1282. Evaluation of Opportunities for Implementing OVIVA Criteria on Patients with Bone and Joint Infections (BJIs) in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Crawford, Garrett, et al.
Publicado: (2023)

Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy
por: D’Couto, Helen T, et al.
Publicado: (2018)

Emergency Department Utilization During Self-Administered Outpatient Parenteral Antimicrobial Therapy
por: Ganguly, Anisha, et al.
Publicado: (2017)

Follow-up Appointment Adherence of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Lall, Ambika, et al.
Publicado: (2017)

777. Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Burnett, Yvonne, et al.
Publicado: (2019)

1301. Assessing Safety and Clinical Outcomes of Outpatient Parenteral Antimicrobial Program in Veterans
por: Rich, William, et al.
Publicado: (2023)

1944. Patients With Prosthetic Joint Infections Receiving Outpatient Parenteral Antimicrobial Therapy: Characteristics and Readmission Rates
por: Gore, Sara, et al.
Publicado: (2018)

Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy: A Cohort Study
por: Kim, So Lim, et al.
Publicado: (2017)

1939. Socioeconomic Predictors of Hospital Readmission in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
por: Hamad, Yasir, et al.
Publicado: (2018)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

622. Risk Factors for 30-Day Unplanned Readmissions in Patients Discharged with Outpatient Parenteral Antimicrobial Therapy
por: Shah, Megan, et al.
Publicado: (2020)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy
por: Jones, Bruce M, et al.
Publicado: (2018)

285. Challenging the Dogmas of Outpatient Parenteral Antimicrobial Therapy Through a Randomized Controlled Trial
por: Ibrahim, Laila, et al.
Publicado: (2018)

1943. Collateral Benefits of Diabetes Management Associated With Self-administered Outpatient Parenteral Antimicrobial Therapy
por: Bhavan, Kavita, et al.
Publicado: (2018)

772. Access Denied: Impact of Insurance Denials for High-Cost Outpatient Parenteral Antimicrobial Therapy
por: Bianchini, Monica L, et al.
Publicado: (2019)

1760. Selection of appropriate inpatients for outpatient parenteral antimicrobial therapy (OPAT) during the COVID pandemic
por: McKnight, Angela Y, et al.
Publicado: (2022)

345. Unaccounted Costs Associated with Different Outpatient Parenteral Antimicrobial Therapy (OPAT) Models of Care
por: Player, Jacob, et al.
Publicado: (2023)

2208. Ten years of the Irish National Outpatient Parenteral Antimicrobial Therapy (OPAT) Registry Data
por: Reidy, Paul, et al.
Publicado: (2023)

744. Infectious Diseases Providers Perspectives Around the Use of Outpatient Parenteral Antibiotic Therapy (OPAT) for Persons Who Inject Drugs (PWID), US, 2022
por: Solomon, Daniel A, et al.
Publicado: (2022)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

774. A New Outpatient Parenteral Antimicrobial Therapy (OPAT) Management Program Reduces Excess Antimicrobial Days of Therapy and Expedites Timely Central Line Removal
por: Kidd, Catherine, et al.
Publicado: (2019)

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy
por: Tuan, Jessica, et al.
Publicado: (2021)

Outpatient Parenteral Antimicrobial Therapy (OPAT) Practices at a Veterans Affairs Hospital: Potential for Pharmacist Impact
por: Yang, Catherine, et al.
Publicado: (2017)

1925. Vancomycin Treatment and Time to Adverse Drug Reactions During Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Duncan, Asajah, et al.
Publicado: (2018)

1941. Comparison of Patient Outcomes in a Pharmacist-Led Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Howe, Zachary, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ihkjq29gknn7329epp7q6p14t